Melku Mulugeta, Best Oliver G, Winter Jean M, Thurgood Lauren A, Kichenadasse Ganessan, Wassie Molla M, Ahmed Muktar, Symonds Erin L
Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, SA, 5042, Australia.
Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Science, University of Gondar, 196, Gondar, Ethiopia.
J Cancer Res Clin Oncol. 2025 Jul 26;151(7):222. doi: 10.1007/s00432-025-06268-w.
Colorectal cancer (CRC) survivors face an increased risk of multiple primary cancers (MPCs), but evidence on MPC-related mortality is limited.
Using data from the South Australian Cancer Registry (1982-2017), this retrospective study analysed CRC survivors diagnosed with MPCs, defined as distinct primary cancers arising ≥ 2 months after CRC diagnosis. Causes of death were categorised as index CRC, MPC, or non-cancer related. Poisson regression estimated cancer-specific mortality risk compared to the general population. Propensity score weighting was applied to balance covariate distribution between CRC survivors with and without MPC groups. A hazard ratio (HR) for all-cause mortality was estimated using a weighted dataset to assess the impact of MPC on overall survival.
Among 26,093 CRC survivors (181,877 person-years follow-up), the age-standardised MPC-related mortality rate was 240 per 100,000 population. Gastrointestinal, lung, haematological, and urinary tract cancers were the most common MPC-related causes of death. CRC survivors had a 45% higher risk of dying from MPCs than the general population (standardised mortality ratio = 1.45, 95%CI 1.38-1.52). Adjusted analyses showed a 58% increase in all-cause mortality among CRC survivors with MPCs (HR = 1.58, 95%CI 1.51-1.65).
CRC survivors with MPC face significantly worse survival compared to those with a single primary CRC. Early detection and management of MPCs are essential for improving long-term survival in individuals diagnosed with CRC.
结直肠癌(CRC)幸存者面临多种原发性癌症(MPC)风险增加的情况,但关于MPC相关死亡率的证据有限。
利用南澳大利亚癌症登记处(1982 - 2017年)的数据,这项回顾性研究分析了被诊断患有MPC的CRC幸存者,MPC定义为在CRC诊断后≥2个月出现的不同原发性癌症。死亡原因分为原发性CRC、MPC或非癌症相关。泊松回归估计与普通人群相比的癌症特异性死亡风险。应用倾向评分加权来平衡有MPC组和无MPC组CRC幸存者之间的协变量分布。使用加权数据集估计全因死亡率的风险比(HR),以评估MPC对总体生存的影响。
在26,093名CRC幸存者(181,877人年随访)中,年龄标准化的MPC相关死亡率为每100,000人口240例。胃肠道、肺、血液和泌尿系统癌症是最常见的MPC相关死亡原因。CRC幸存者死于MPC的风险比普通人群高45%(标准化死亡率比 = 1.45,95%CI 1.38 - 1.52)。调整分析显示,患有MPC的CRC幸存者全因死亡率增加58%(HR = 1.58,95%CI 1.51 - 1.65)。
与单一原发性CRC患者相比,患有MPC的CRC幸存者生存情况明显更差。早期检测和管理MPC对于改善CRC诊断患者的长期生存至关重要。